April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Jun Gong: Dr. Fang PhI trial hypoxia-responsive CEA CAR-T in refractory solid tumors
Jun 7, 2024, 06:44

Jun Gong: Dr. Fang PhI trial hypoxia-responsive CEA CAR-T in refractory solid tumors

Jun Gong, Medical oncologist and researcher in gastrointestinal and genitourinary cancers at Cedars-Sinai, shared a post on X:

Dr. Fang PhI trial hypoxia-responsive CEA CAR-T in refractory solid tumors (35/40 #mCRC pts) enrolled to IV or IP administration depending on predominant peritoneal Mets. IP ORR 25% vs 8% IV, 100% G3-4 heme toxicity, G1-2 CRS 62.5% all patients.

Jun Gong

Source: Jun Gong/X